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NELF, a Multisubunit Complex Containing RD,
Cooperates with DSIF to Repress
RNA Polymerase II Elongation
phosphorylation may be a prerequisite for the success-
ful completion of transcription. Studies to date, how-
ever, have failed to address this issue. No difference
has been observed between the efficiencies of pol IIo
and hypophosphorylated pol II (pol IIa) during elongation
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Japan in vitro systems (Zehring et al., 1988; Serizawa et al.,
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Kyowa Hakko Kogyo Company, Ltd. DRB is unique in that it shows no effect on transcrip-
tion reconstituted with purified general transcription fac-Machida, Tokyo 194-8533
Japan tors (GTFs) and pol II, while it potently represses tran-
scription in more crude systems and in vivo (Yamaguchi
et al., 1998 and references therein). Therefore, factors
different from GTFs and pol II must be involved in DRB-Summary
sensitive transcription. Recently, we and others have
identified two such elongation factors, namely DSIF andDRB is a classic inhibitor of transcription elongation
P-TEFb. DSIF (for DRB sensitivity-inducing factor) re-by RNA polymerase II (pol II). Since DRB generally
presses transcription in the presence of DRB, therebyaffects class II genes, factors involved in this process
inducing DRB sensitivity (Wada et al., 1998a, 1998b;must play fundamental roles in pol II elongation. Re-
Yamaguchi et al., 1999). DSIF is composed of two sub-cently, two elongation factors essential for DRB action
units, which are homologs of the Saccharomyces cere-were identified, namely DSIF and P-TEFb. Here we
visiae transcription factors Spt5 and Spt4, respectivelydescribe the identification and purification from HeLa
(Swanson et al., 1991; Winston, 1992; Hartzog et al.,nuclear extract of a third protein factor required for
1996). DSIF/Spt4-Spt5 genetically and physically inter-DRB-sensitive transcription. This factor, termed nega-
acts with pol II and may directly regulate pol II processi-tive elongation factor (NELF), cooperates with DSIF
vity (Hartzog et al., 1998; Wada et al., 1998a, Yamaguchiand strongly represses pol II elongation. This repres-
et al., 1999). On the other hand, P-TEFb (positive tran-sion is reversed by P-TEFb-dependent phosphoryla-
scription elongation factor b) stimulates elongation in ation of the pol II C-terminal domain. NELF is composed
DRB-sensitive fashion, and the low level of transcriptionof five polypeptides, the smallest of which is identical
in the absence of P-TEFb is not affected by DRB (Mar-to RD, a putative RNA-binding protein of unknown
shall and Price, 1992, 1995; Zhu et al., 1997). P-TEFbfunction. This study reveals a molecular mechanism
turns out to be a DRB-sensitive protein kinase that isfor DRB action and a regulatory network of positive
composed of CDK9 and cyclin T and phosphorylatesand negative elongation factors.
the pol II CTD (Marshall et al., 1996; Zhu et al., 1997;
Peng et al., 1998). Based on these data, a model hasIntroduction
been proposed in which P-TEFb alleviates the negative
effect of DSIF by phosphorylating the pol II CTD (Yama-The elongation step of transcription is now recognized
guchi et al., 1998). We have recently obtained evidenceas a critical target for transcription regulation. An in-
in line with this model using a crude transcription systemcreasing number of elongation factors have been identi-
(Wada et al. 1998b). Nevertheless, DSIF alone had nofied, and the regulatory mechanism of elongation seems
effect on purified pol II (see below), and as such, thereto be as complex as that of transcription initiation (re-
remain many obstacles to be overcome before we canviewed in Reines et al., 1996; Uptain et al., 1997; Shilati-
arrive at a complete understanding of the mechanismfard, 1998). The role played by the phosphorylation of
of DRB-sensitive transcription elongation.the repetitive C-terminal domain (CTD) of pol II during
To further characterize this process, we have estab-elongation remains a major enigma. The CTD becomes
lished a more defined transcription system that reconsti-extensively phosphorylated during the transition from
tutes DRB sensitivity in vitro. In this system employingtranscription initiation to elongation and remains phos-
recombinant GTFs and DSIF plus some partially purifiedphorylated during elongation (Dahmus, 1996 and refer-
fractions, a requirement for an additional factor in DRB-ences therein). A nucleoside analog DRB is a specific
sensitive transcription has emerged. The factor termedinhibitor of pol II elongation and of certain protein ki-
NELF represses pol II elongation in conjunction withnases. Application of the drug markedly reduces the
DSIF but appears to be normally counteracted by P-TEFb-synthesis of mRNA and, at the same time, eliminates
dependent phosphorylation of the pol II CTD. This studyphosphorylated pol II (pol IIo) from the cells (Sehgal
reveals a molecular mechanism for DRB action and aet al., 1976; Dubois et al., 1994), suggesting that CTD
novel aspect of CTD phosphorylation. Interplay between
these positive and negative elongation factors may de-
termine the fate of pol II, deciding between processive³ To whom correspondence should be addressed (e-mail: hhanda@
bio.titech.ac.jp). and abortive elongation.
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adenovirus E4 promoter (Wada et al., 1991). We utilized
two different preparations of DSIF, a concentrated mix-
ture of P.1 and P.3 achieved by ammonium sulfate pre-
cipitation (a P.1/P.3 concentration) and purified rDSIF.
Using the P1.0 fraction, both DSIF preparations con-
verted DRB-insensitive transcription to DRB-sensitive
transcription (Figure 1B), in agreement with our previous
results (Wada et al., 1998a). In the reconstituted system,
however, the addition of a P.1/P.3 concentration gave
DRB sensitivity, but rDSIF did not (Figure 1C, compare
lanes 1 and 2, and 11 and 12). This raised the possibility
that an additional activity present in the crude DSIF
preparation (i.e., either P.1 or P.3) was required for DRB-
sensitive transcription. To test this, increasing amounts
of P.1 or P.3 were added together with rDSIF to the
reconstituted system. Within a range of P.3 concentra-
tions that had little effect alone (lanes 5±10), P.3 and
rDSIF together dramatically induced DRB sensitivity
Figure 1. Identification of the Activity Required for DRB-Sensitive (lanes 13±18). P.1 did not have such an effect (data
Transcription
not shown). These results indicate that the P.3 fraction
(A) Diagram showing the reconstitution of DRB-sensitive transcrip-
contains another DRB sensitivity±inducing activity. Thistion. HeLa nuclear extract was first applied to a phosphocellulose
activity may also be present in the P1.0 fraction, since(P11) column, yielding three fractions, P.1, P.3, and P1.0. P1.0 was
purified rDSIF was sufficient when P1.0 was used insufficient for transcription and was further fractionated on DEAE
Sepharose and phenyl Superose columns. place of the reconstituted system (Figure 1B).
(B) Transcription in the crude P1.0 system. Using the P1.0 fraction,
the effect of crude (P.1/P.3 conc) and purified (rDSIF) preparations
of DSIF was compared. Both were found to equally induce DRB
Purification of NELFsensitivity.
We termed the novel factor NELF, since it represses pol(C) Transcription in the reconstituted system. The effect of crude and
II elongation (see below). Using the reconstituted systempurified DSIF preparations was compared using the reconstituted
system containing the phenyl flowthrough (φFT), rTFIIB, rTFIIE, and plus rDSIF as an assay, NELF was purified from P.3 as
rTFIIF. rDSIF alone did not induce DRB sensitivity in this system summarized in Figure 2A. NELF was separated from
(lanes 11 and 12). Further addition of P.3 (P.3 dil) restored DRB DSIF at the DEAE Sepharose step (data not shown).
sensitivity (lanes 13±18), indicating the presence of another DRB
During the course of purification, however, we noticedsensitivity±inducing activity in P.3.
that the effect of DRB gradually decreased. We sus-
pected that P-TEFb might be limiting in the reaction and
supplemented the reaction with a P-TEFb active fractionResults
prepared as described in Experimental Procedures. The
addition of the P-TEFb fraction fully restored DRB sensi-Identification of Another DRB
tivity, and thus we were able to measure NELF activitySensitivity±Inducing Activity
up to the last purification step. In the mono S fractions,In a previous study (Wada et al., 1998a), we fractionated
NELF activity was found between fractions 22±26 onlyHeLa nuclear extract by phosphocellulose column chro-
in the presence of P-TEFb (Figure 2B, top). Finally, wematography into four fractions, which we referred to as
established a transcription system that induces DRBP.1, P.3, P.5, and P.85 (the number denotes the KCl
sensitivity, depending on three different factors, NELF,concentration of the elution buffer). Pol II and most of
DSIF, and P-TEFb.the GTFs were found in fractions P.5 and P.85, and a
SDS-PAGE and silver staining of the mono S fractionscombination of these two fractions reconstituted tran-
revealed five different bands of 66, 61, 59, 58, and 46scription activity. However, this transcription was not
kDa associated with NELF activity (Figure 2B, bottom).sensitive to DRB, which could only be restored when
On the next gel filtration column, these polypeptidesthe reaction was supplemented with either fractions P.1
were coeluted between fractions 5±9, indicating thator P.3. Using such assays, we were able to purify DSIF
they comprised one multimeric complex with a molecu-from P.1 and P.3 (Wada et al., 1998a).
lar mass of z300 kDa (Figure 2D). NELF activity wasTo understand the mechanism of DRB action, a more
present in these fractions, but this activity was low duedefined transcription system that reconstitutes DRB
to protein dilution. We refer to the five polypeptidessensitivity was required. To this end, fraction P1.0 (the
as NELF-A to -E in accordance with their decreasing0.3±1.0 M KCl step from P11 and almost relevant to a
molecular weights. Since the five bands had roughly themixture of P.5 and P.85) was passed through DEAE
same intensity after silver staining, they may form aSepharose and phenyl Superose columns as outlined
heteropentamer.in Figure 1A. At this phenyl Superose step, general tran-
We next assessed the functional relationship betweenscription could be reconstituted with recombinant (r)
NELF and P-TEFb (Figure 2C). Without P-TEFb, NELFTFIIB, rTFIIE, rTFIIF, and the phenyl flowthrough fraction
potently repressed transcription irrespective of the pres-(φFT), which contains TFIID, TFIIH, and pol II. As a tem-
ence of DRB (lanes 1±6). The addition of the P-TEFbplate, we used a supercoiled plasmid pTF3-6C2AT car-
rying a 380 bp G-free cassette under the control of the fraction resulted in a partial reversal of the repressed
A Novel, Negative Transcription Elongation Factor
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Figure 2. Purification of Negative Elongation
Factor
(A) Scheme for NELF purification. NELF was
purified from P.3 using the reconstituted sys-
tem plus rDSIF as an assay. P-TEFb derived
from P1.0 was additionally included in the
reactions at later steps of purification.
(B) NELF activity on the mono S column.
Mono S fractions (2 ml) were assayed for NELF
activity in the presence or absence of P-TEFb.
NELF activity was found in fractions 20±26
only in the presence of P-TEFb. The mono S
fractions (2 ml) were also resolved by 7.5%
SDS-PAGE, and the gel was stained with sil-
ver. Five different bands of 66, 61, 59, 58, and
46 kDa (indicated by arrows) were associated
with the activity. IN, input; FT, flowthrough.
(C) Transcription repression by NELF. The ef-
fect of purified NELF (mono S) was examined
in the presence or absence of P-TEFb as in
(B). Without P-TEFb, NELF potently repressed
transcription, while the addition of P-TEFb
partly relieved the repression in a DRB-sensi-
tive manner.
(D) Gel filtration of purified NELF. Fifty microli-
ters purified of NELF (mono S) was applied
to a Superdex 200 gel filtration column. An aliquot (10 ml) of each eluate fraction was assayed for NELF activity in the presence of P-TEFb
as in (B), or stained with silver. The five polypeptides were coeluted with NELF activity at an apparent molecular mass of z300 kDa and
termed NELF-A to -E in accordance with their decreasing molecular weights. The positions of the native molecular weight markers are indicated
at the bottom.
transcription (lanes 7±12). The restored transcription can be efficiently transcribed by purified pol II without
any GTFs and has been used for assaying general elon-was sensitive to DRB, indicating that P-TEFb alone was
responsible for the alleviation. The slight reduction in gation factors such as TFIIF and Elongin (Kitajima et al.,
1994; Aso et al., 1995). The addition of rDSIF had notranscription seen after the addition of the P-TEFb frac-
tion to assays containing DRB (lanes 8, 10, and 12) could effect in this system (Figure 3C, lanes 1±8), and NELF
alone slightly repressed pol II transcription reproduciblynot be reproduced when purified rP-TEFb was used
instead of the P-TEFb fraction (data not shown). This (lanes 9±12). In contrast, a marked inhibition was ob-
served when both were added together (lanes 13±16).discrepancy might be due to certain contaminating fac-
tors present in the P-TEFb fraction. Taken together, Therefore, we conclude that DSIF and NELF exert a
negative effect directly on pol II. Proteins used in thisthese results indicate (a) that NELF represses transcrip-
tion in the absence of P-TEFb, and (b) that P-TEFb some- assay were analyzed by SDS-PAGE and silver staining
(Figure 3B). Pol II was mostly in the IIa form, and rDSIFhow counteracts this repression.
(2 ml) and purified NELF (2 ml) were present in excess
over pol II. The amounts of pol II and P-TEFb presentNELF Acts Cooperatively with DSIF
in the reconstituted system were roughly the same asTo elucidate the relationship between DSIF and NELF,
the amounts of these factors, as estimated by immu-we next tested their effect in the reconstituted system
noblotting (data not shown).lacking P-TEFb (Figure 3A). A template pML-dC2AT car-
rying a 270 bp G-free cassette under the control of the
adenovirus major late promoter (Watanabe et al., 1990) Effect of DSIF and NELF on Different Forms of Pol II
P-TEFb counteracts the repression induced by DSIFwas additionally used in the following assays. DSIF or
NELF alone had little effect. In contrast, they repressed and NELF (Figure 2C). Since the pol II CTD has been
suggested to be a primary target for phosphorylationtranscription from the E4 promoter when added together
and, at the same time, resulted in the accumulation of by P-TEFb, it seems reasonable to propose that CTD
phosphorylation modulates the negative effect of DSIFshorter transcripts. Thus, DSIF and NELF cooperatively
repress transcription. pML-dC2AT was less sensitive and and NELF. To test this, pol IIo, pol IIa, and the CTD-
less form of pol II (pol IIb) were prepared, and theirrequired higher doses of DSIF/NELF for repression (for
example, compare lanes 2, 4, and 6 of Figure 5C). The susceptibility to DSIF and NELF was compared. The
integrity of these polymerases was verified by silverdifferential effect is not due to the nature of the promot-
ers but reflects primarily the difference in transcript staining (Figure 3D). In the absence of DSIF and NELF,
the three forms of pol II showed similar elongation activ-length between the templates (Figure 7 and data not
shown). ity, indicating that neither the presence of the CTD nor
its phosphorylated state affects elongation of purifiedSince DSIF physically interacts with pol II (Wada et
al., 1998a; Yamaguchi et al., 1999), DSIF and NELF might pol II (Figure 3E). On the other hand, the addition of
DSIF and NELF strongly repressed pol IIa but not poldirectly inhibit pol II transcription. To test this possibility,
we employed an oligo dC-tailed template. This template IIo. To verify this further, pol IIa was converted to the
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Figure 3. NELF Acts Cooperatively with DSIF
to Repress Pol II Transcription
(A) Cooperative action of DSIF and NELF on
promoter-specific transcription. The indicated
amounts of r-DSIF and NELF (mono S) were
added to the reconstituted system lacking
P-TEFb. Two transcripts are generated from
the adenovirus E4 and major late (ML) pro-
moters. Transcripts from the ML promoter are
less sensitive to repression. The vertical bar
indicates the accumulation of short transcripts
caused by DSIF and NELF.
(B) Proteins used in (C) were resolved by 7.5%
(left) or 12.5% (right) SDS-PAGE and stained
with silver. The amounts used are purified pol
II, 0.5 ml; rDSIF, 2 ml; purified NELF, 2 ml. Pol
II was mostly in the IIa form.
(C) Cooperative action of DSIF and NELF on
the oligo dC-tailed template. Purified pol II
and the template were preincubated together
with the indicated protein factors. NTPs were
added, and elongation was allowed to pro-
ceed for the indicated times.
(D) Pol IIo, pol IIa, and pol IIb were prepared
as described in Experimental Procedures,
and the amounts used in (E) were analyzed
by 7.5% SDS-PAGE and silver staining.
(E) The different forms of pol II were assayed
for elongation in the presence or absence of
DSIF and NELF (2 ml each). Pol IIa and pol
IIb, but not pol IIo, were susceptible to DSIF
and NELF.
IIo form using P-TEFb and dATP and used in the assay. NELF (lane 2). In addition, RD cofractionated with NELF
activity through several purification steps (unpublishedThe IIo form thus prepared was also resistant to DSIF
and NELF (data not shown). From these results, we con- data). Thus, we conclude that NELF-E is identical to RD.
Importantly, RD was found in both P.3 and P1.0, but notclude that CTD phosphorylation by P-TEFb (and possi-
bly other kinases) makes pol II resistant to repression in P.1 (data not shown). This observation provides an
answer as to why there was no requirement for NELFby DSIF and NELF. Since pol IIb was susceptible to
when the original P1.0 system was employed (Figure 1B).DSIF and NELF (Figure 3E), the CTD is dispensable for
the repression.
Immunodepletion of NELF from HeLa
Nuclear Extract
To determine whether NELF-E/RD is required for NELFMolecular Cloning of NELF-E
activity, RD was immunodepleted from HeLa nuclearTo determine the identity of NELF complex, the NELF
mono S fractions were subjected to SDS-PAGE, and the
band of 46 kDa corresponding to NELF-E was excised
and subjected to Lysyl-C digestion. Two peptide se-
quences were obtained for microsequence analysis. In
a search of the databases, the two sequences were
found to match part of the predicted human RD protein
(Levi-Strauss et al., 1988; Cheng et al., 1993). RD is a 380
amino acid protein with a calculated molecular weight of
43.2 kDa, a size that roughly agrees with that of NELF-E.
The RD protein, whose function is unknown, was named
RD because it possesses the unique Arg-Asp (RD) di-
peptide repeat sequence (Figure 4). RD also contains a
putative RNA recognition motif (RRM) in its C terminus
and a leucine zipper in its N-terminal end.
Figure 4. Identification of NELF-E as RDTo confirm the identity of RD as NELF-E, an antibody
The active fractions from mono S were subjected to SDS-PAGE,was raised against the full-length RD protein. The anti-
and the band of 46 kDa corresponding to NELF-E was subjectedbody was highly specific, since it exclusively reacted
to microsequence analysis. Two peptide sequences (underlined)with the z46 kDa band of RD in the crude nuclear extract
were obtained and found to match parts of the human RD protein
(Figure 5A, lane 1). It was then used to examine for the (Cheng et al., 1993; GenBank accession No. L03411). The RD motif
presence of RD in purified, as well as in crude, NELF and the putative RRM are indicated by arrows. Asterisks denote
Leu residues of the putative leucine zipper structure.fractions. The antibody clearly detected RD in purified
A Novel, Negative Transcription Elongation Factor
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Figure 6. NELF Interacts with DSIF and Pol II
Nuclear extracts were prepared from HeLa/Flag-RD and control
HeLa cells by the method of Dignam et al. (1983). The extracts (200
ml) were immunoprecipitated with anti-Flag M2 monoclonal antibody
(Sigma) under transcription conditions, washed, and eluted with
Flag peptide (Sigma). Each fraction was analyzed by immunoblotting
with the indicated antibodies. Input and FT lanes represent 4% of
the total amount.
were added back to the depleted extract (Figure 5D). In
both cases, the addition of NELF repressed transcription
in the presence of DRB and restored DRB sensitivity.
Figure 5. Immunodepletion of NELF from HeLa Nuclear Extract Thus, RD is responsible, at least in part, for NELF activ-
(A) Specificity of anti-RD antibody. Anti-RD antibody raised against ity. These results also fit with the model that NELF is a
the full-length RD protein was tested for immunoblotting. The anti- negative factor normally counteracted by P-TEFb. In
body detected a single band of z46 kDa in the nuclear extract and
contrast, histidine-tagged (His-) RD purified from Esche-purified NELF (mono S).
richia coli could not restore DRB sensitivity (unpublished(B) Immunoblot analysis of the nuclear extracts depleted of RD.
data). It is therefore likely that the other NELF subunitsHeLa nuclear extract (200 ml) was repeatedly passed over protein
G-Sepharose (20 ml) to which either anti-RD or preimmune serum are also essential for its function and were depleted,
was adsorbed. The supernatants (2 ml) were analyzed for the pres- in addition to RD, from the extract using the anti-RD
ence of RD, DSIF p160, the CDK9 subunit of P-TEFb, and the largest column.
subunit of pol II by immunoblotting. Two or four passages over the
anti-RD beads reduced or eliminated the endogenous RD protein
NELF Interacts with DSIF and Pol II(DRDx2 and DRDx4), while the level of other components remained
To elucidate the molecular basis for NELF action, weconstant. Depletion with the control beads had no effect.
(C) Transcription activity of the RD-depleted extract. The extracts investigated the physical interaction between NELF and
(2 ml) were assayed using pTF3-C2AT and pML-dC2AT. Depletion of the other components of the DRB-sensitive transcrip-
RD did not significantly affect transcription in the absence of DRB. tion machinery. Nuclear extracts were prepared from
In its presence, however, RD depletion alleviated transcription re-
HeLa cells constitutively expressing Flag-tagged RDpression, resulting in a reduction in DRB sensitivity.
(HeLa/Flag-RD; Y. Y. and H. H., unpublished data) and(D) Readdition of NELF. D.225 signifies the 0.225 M KCl fraction
control HeLa cells. Flag-RD-containing complexes werefrom DEAE Sepharose, which was free from DSIF. D.225 (6 ml) and
purified NELF (mono S; 2 ml) were added back to the RD-depleted purified from the extracts by anti-Flag affinity chroma-
extract (DRDx4). In both cases, the addition of NELF repressed tography, and the presence of various components was
transcription in the presence of DRB and restored DRB sensitivity. examined by immunoblotting. Flag-RD and the other
NELF subunits were quantitatively recovered in the im-
munoprecipitate, while endogenous RD was found in
extract using the anti-RD antibody. The nuclear extract the supernatant (Figure 6 and data not shown). Under
was passed through an anti-RD antibody±immobilized these conditions, a fraction of DSIF p160 and pol II
column or a control column twice or four times, and was coprecipitated with Flag-RD, indicating that they
the presence of RD was monitored by immunoblotting physically interact with NELF. P-TEFb was not detected
(Figure 5B). After four passages, virtually all of the en- in the immunoprecipitate.
dogenous RD protein was removed from the extract. The antibody 8WG16 recognizes both pol IIo and pol
The procedure did not significantly affect the protein IIa (Thompson and Burgess, 1996). However, since pol
levels of DSIF, pol II, or P-TEFb (Figure 5B). II in the nuclear extract is mostly in the IIa form, it is
We next assessed the transcription activity of these difficult to detect pol IIo. To determine whether NELF
extracts using the two templates referred to in Figure interacts with pol IIo, another antibody B3, which specifi-
3A (Figure 5C). The depletion of RD increased the level cally recognizes pol IIo, was employed (Mortillaro et al.,
of transcription in the presence of DRB without affecting 1996). In striking contrast to pol IIa, pol IIo was absent
the basal level, which resulted in a marked reduction from the immunoprecipitate. Thus, CTD phosphoryla-
of DRB sensitivity. Crude (D.225, a DEAE Sepharose tion directly controls the interaction between NELF and
pol II.fraction free from DSIF) or purified NELF preparations
Cell
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Figure 7. Kinetic Analysis of DSIF/NELF Function
(A) Primer extension analysis. Transcripts were synthesized from pTF3-6C2AT using either the normal HeLa nuclear extract in the presence
or absence of 50 mM DRB (left) or the extract depleted of NELF and P-TEFb with or without 1 ml NELF (right). They were analyzed using a
set of oligonucleotide primers labeled to the same specific activity. M lanes show the pBR322 MspI digest. The extension products, marked
with the dots, were quantified using a FLA-2000 image analyzer (Fuji), and the amounts (in arbitrary units) were plotted against the length
from the transcription start site (top). Indicated in the inset are the positions of transcripts to which the primers hybridized. Longer transcripts
may be underestimated due to the reduced efficiency of reverse transcription.
(B) Effect of DSIF and NELF on isolated elongation complexes. Purified pol II and the oligo dC-tailed template carrying a 380 nt C-free cassette
at its dC end were incubated in the presence of NTP lacking CTP, and the paused elongation complexes were allowed to form on the template.
DSIF and NELF were added where indicated, and elongation was allowed to resume for the indicated times by adding CTP.
Kinetic Analysis of DSIF/NELF Action positions 120 and 140. This may be due to promoter-
proximal pausing, which reportedly occurs at the pro-Which step(s) of transcription is affected by DSIF and
moter clearance step and which is suppressed by TFIIHNELF? While several lines of evidence indicate that they
in an ATP-dependent manner (Dvir et al., 1997; Kumaract on elongation, the above data showing DSIF/NELF
et al. 1998). In agreement with a previous report (Cho-interaction with pol IIa raise the possibility that they may
dosh et al., 1989), however, production of such shortalso affect earlier steps of transcription such as initiation
transcripts (20±40 nt) was neither sensitive to DRB (left)and promoter clearance. To elucidate their role in these
nor to NELF (right), indicating that DSIF and NELF dosteps, we performed primer extension assays (Figure
not inhibit initiation and subsequent promoter clearance7A). Transcripts were synthesized from pTF3-6C2AT us-
steps. In contrast, elongation complexes synthesizinging either the normal nuclear extract (left) or the extract
50±60 nt or longer transcripts were sensitive to DRB anddepleted of NELF and P-TEFb (right), and the transcripts
NELF, which were relatively processive in their absence.were analyzed using a set of oligonucleotide primers.
The qualitative change seems to occur between posi-In the former case, DRB sensitivity was examined, and
tions 130±40 and 150±60 in a sequence-independentin the latter case, the extent of NELF repression was
manner, because the same transition was observed us-
directly measured in the absence of P-TEFb. The above
ing a different template (data not shown). Since longer
graphs show the survival curves of transcription com-
transcripts were more sensitive to DRB and NELF, it is
plexes as a function of their distance from the transcrip- likely that DSIF and NELF can act on elongation com-
tion start site. Note that the extension products reflect plexes located even further downstream.
the amount of transcription through the primer positions To directly determine whether DSIF and NELF act
as well as the amount of shorter transcripts which can on isolated elongation complexes, the oligo dC-tailed
anneal to the 39-portion of the primers. This limits the template was devised to carry a 380 bp C-free cassette
resolution of the assay, which is, however, still higher at its dC end. Purified pol II and the template were
than those of previous studies (Chodosh et al., 1989; incubated in the presence of NTP lacking CTP, and the
Marciniak and Sharp, 1991). paused elongation complexes were allowed to form on
We observed that a significant fraction of the initiated the template (Figure 7B, lane 1). Addition of CTP allowed
the polymerase to resume RNA synthesis (lanes 2±5).complexes encountered a block to elongation between
A Novel, Negative Transcription Elongation Factor
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Addition of DSIF and NELF before CTP addition greatly
reduced elongation by the paused pol II (lanes 6±15),
indicating that DSIF and NELF exert a negative effect on
elongation complexes that have transcribed stretches of
DNA of several hundred nucleotides.
Discussion
Interplay between Positive and Negative
Elongation Factors
Most of the general elongation factors known to date
possess stimulatory functions. One exception is factor
2, which causes the release of pol II transcripts in an
ATP-dependent manner (Xie and Price, 1996; Liu et al.,
1998). In this and previous studies (Wada et al., 1998a),
we have identified a novel class of elongation factors
that cause pol II pausing. Since DRB-induced short tran-
scripts can be chased by the addition of high concentra-
tions of NTP (Wada et al., 1998a), the repression by DSIF Figure 8. Interplay between DSIF, NELF, and P-TEFb
and NELF is not due to termination, but rather to pausing
by pol II. As is often seen in other biological reactions (Samkurashvili and Luse, 1998). Thus, DSIF and NELF
such as homeostasis, well-tuned regulation can only presumably act on mature elongation complexes.
be achieved through the action of both positive and Several groups have reported that actively elongating
negative factors. polymerases contain the hyperphosphorylated CTD
From the current data, we propose a plausible model (Dahmus, 1996; Uptain et al., 1997). However, DSIF and
for the interplay between DSIF, NELF, and P-TEFb. In a NELF can only associate with, and inhibit, hypophos-
highly purified system (Figure 8A), transcription elonga- phorylated pol II. Addition of DRB or depletion of P-TEFb
tion is processive (after the promoter clearance step) may create an unusual situation in which the CTD of
and insensitive to DRB, since both the positive and neg- elongating pol II remains hypophosphorylated, thereby
ative factors are absent. In a more crude system (Figure allowing DSIF/NELF to repress elongation continuously.
8B), DSIF and NELF bind pol IIa and repress elongation. If so, at which step do DSIF and NELF act under physio-
However, P-TEFb normally phosphorylates the pol II logical conditions? The most probable step is early elon-
CTD and thereby facilitates the release of DSIF/NELF gation after the transcription complex becomes sensi-
from pol II, which alleviates the block to elongation. We tive to DSIF/NELF. At this step, polymerases are often
have recently found that the DSIF±pol II interaction is found in the unphosphorylated state (O'Brien et al,
also sensitive to CTD phosphorylation (Wada et al., 1994). Kinetic analyses of P-TEFb also suggest a posi-
1998b). In the presence of DRB, P-TEFb action is inhib- tive role in early elongation (Marshall and Price, 1992).
ited, allowing DSIF/NELF to continue to repress elonga- As an alternative possibility, DSIF/NELF may affect elon-
tion. Since DRB affects most of the class II genes, the gation complexes located further downstream. Re-
repression±antirepression process likely represents a cently, a protein phosphatase specific for pol IIo was
critical rate-limiting step in pol II elongation. identified in humans and yeast (Chambers et al., 1995;
The CTD is dispensable for repression by DSIF and Archambault et al., 1997, 1998). Though its action mech-
NELF, since pol IIb was susceptible to DSIF and NELF anism remains obscure, it seems possible that the CTD
as well as pol IIa (Figure 3E). Therefore, DSIF and NELF phosphatase dephosphorylates the pol II CTD during
most likely bind another region of pol II distinct from the the elongation process. If this happens, DSIF and NELF
CTD. CTD phosphorylation may induce a conformational may become reassociated with, and cause pausing of,
change in pol II that could mask the interaction domain. this pol II.
Alternatively, phosphorylated CTD may perturb the as- The data described above pose another question:
sociation of DSIF and NELF with pol II ionically. It is Why don't DSIF and NELF repress the initiation and
also possible that NELF binds the nascent transcript promoter clearance steps? Since pol II recruited to pro-
through the RD subunit to stabilize the ternary complex moters is in the hypophosphorylated form (Dahmus,
(Figure 8). 1996), DSIF/NELF would be expected to interact with
pol II and repress these steps. However, this interpreta-
tion is not supported by the data presented above. AMechanism for Repression by DSIF and NELF
Primer extension analysis revealed that DSIF and NELF possible explanation is that DSIF/NELF may not be able
to associate with pol II during these steps. Since pol IIdo not affect promoter-proximal transcription. These
results as well as those of the oligo dC-tailed template molecules are assembled into very large protein com-
plexes at the promoter, this may prohibit DSIF/NELFassays indicate that DSIF and NELF are capable of re-
pressing transcription at any point downstream of 150± from associating with pol II. Upon promoter clearance,
the pol II complex may become ªnakedº and accessible60. The initiated polymerases pass through a structural
transition at around 125, and after the synthesis of z40 to repression by DSIF and NELF. Alternatively, DSIF/
NELF may be incorporated into the initiation complexnt transcripts they form stable elongation complexes
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but be unable to exert a negative effect during the early argue against the model because (a) RD exists solely in
the context of NELF (unpublished data) and (b) NELFsteps of transcription. If this were the case, DSIF/NELF
must repress some pol II function(s) specific to the elon- does not interact with pol IIo, a form involved in mRNA
splicing (Mortillaro et al., 1996; Corden and Patturajan,gation phase. It will be interesting to determine whether
DSIF and NELF are present in the preinitiation and post- 1998). It will be important to determine whether NELF
has any RNA binding activity and whether this is criticalinitiation complexes. Future analyses should shed more
light on the mechanism of DSIF and NELF transcription for its function. The Tat protein encoded by HIV is a well-
characterized transactivator with RNA binding activityrepression.
(Jones and Peterlin, 1994). Tat targets the specific RNA
element downstream of the HIV long terminal repeat andFunctional Roles of CTD Phosphorylation
stimulates elongation. Thus, NELF may also recognizeAlthough the roles played by the pol II CTD and its
RNA in a sequence-specific manner and may be recruitedphosphorylation have been extensively studied, their
to some cis-acting elements to cause gene-specific androles in processive elongation are poorly understood.
site-specific pol II pausing.Here we demonstrate that CTD phosphorylation facili-
tates the release of the negative elongation factors DSIF
and NELF from pol II. Conversely, a novel elongation
Experimental Procedures
factor complex termed Elongator was recently identified
in yeast. Elongator selectively binds pol IIo, and genetic Transcription Factors and Pol II
evidence suggests that it plays a positive role in elonga- The HeLa nuclear extract and the phosphocellulose (P11) fractions
(P.1, P.3, and P1.0) were prepared as described (Wada et al., 1998a).tion (Otero et al. 1999). In addition, a number of proteins
To establish a more defined transcription system that reconstituteshave been reported that interact with pol II in a CTD
DRB sensitivity, P1.0 was dialyzed against HGE (20 mM HEPES [pHphosphorylation state-sensitive manner. Some GTFs
7.9], 20% glycerol, 0.2 mM EDTA, 0.5 mM dithiothreitol) containing
and a Srb complex bind pol IIa and play roles during 0.1 M KCl (HGE.1; the number following HGE denotes the molar
the initiation phase (Maxon et al., 1994; Sun et al., 1998). concentration of KCl) and applied to a 60 ml DEAE Sepharose FF
column (Amersham Pharmacia) equilibrated with HGE.1. The columnThe 59-capping enzyme binds pol IIo and is recruited to
was washed with the same buffer, and proteins were eluted withthe elongation complex (Cho et al., 1997; McCracken et
HGE.3 and HGE1.0. The 0.3 M KCl fraction was dialyzed againstal., 1997; Yue et al., 1997). Some splicing factors also
HGE containing 1.0 M (NH4)2SO4 and then applied to a phenyl Su-appear to bind pol IIo (Mortillaro et al., 1996; Corden perose HR5/5 column (Amersham Pharmacia; 1.0 ml). Proteins were
and Patturajan, 1998). Thus, CTD phosphorylation func- eluted with a 15 ml linear gradient of 1.0 to 0 M (NH4)2SO4. At this step,
tions as a molecular switch, altering the accessibility of transcription could be reconstituted with the phenyl flowthrough
fraction (φFT), rTFIIB, rTFIIE, and rTFIIF. φFT contains TFIID, TFIIH,pol II to various factors involved in transcription initia-
and pol II. The recombinant GTFs were prepared as described (Wadation, elongation, and mRNA processing.
et al., 1998a). To prepare a P.1/P.3 concentration, 12 ml each ofThere remains an important, unsolved question. Many
P.1 and P.3 were mixed and precipitated with saturated (NH4)2SO4.protein kinases, such as P-TEFb, TFIIH, Srb10-Srb11, Following centrifugation at 13,600 3 g, the pellet was resuspended
DNA-PK, MAPK, and Abl, reportedly phosphorylate the in 3 ml 0.53 HGE.05 and dialyzed against the same buffer. rDSIF
pol II CTD in vivo and/or in vitro (Dahmus, 1996). Does is a mixture of equimolar amounts of r-p160 and r-p14. For P-TEFb,
P1.0 was chromatographed as above, and the presence of P-TEFbCTD phosphorylation by these different kinases have
was monitored by immunoblotting and CTD kinase assays. P-TEFbthe same consequences? A hint as to how this question
activity was found in the eluate of the phenyl Superose column, andmight be answered was provided recently (Hengartner
active fractions were pooled and used as the P-TEFb fraction. Pol
et al., 1998; Sun et al., 1998). Though TFIIH and Srb10- II used in Figure 3B was prepared from HeLa nuclear pellet as
Srb11 both belong to the cyclin-CDK family of protein described (Usuda et al., 1991). In Figure 4, pol IIa and pol IIo were
separately purified to near homogeneity as described (Kim and Dah-kinases, they have opposing functions in general tran-
mus, 1988; Lu et al., 1991). For pol IIb, pol IIa was converted to polscription. It was shown that these kinases phosphory-
IIb by mild treatment with 0.25 mg/ml chymotrypsin for 30 min atlate different residues of the CTD in a temporarily distinct
308C.
manner. Thus, as a first step, it should be determined
whether DSIF and NELF respond differently to the CTDs
Promoter-Specific Transcription Assaysphosphorylated by distinct kinases.
Supercoiled plasmids pTF3-6C2AT and pML-dC2AT were used as
templates, which produce 380 and 270 nt G-free transcripts under
Structure of NELF the control of the adenovirus E4 and major late promoters, respec-
NELF is likely to be composed of RD and four additional tively (Watanabe et al., 1990; Wada et al., 1991). Twenty microliter
reactions containing pTF3-6C2AT (25 ng), pML-dC2AT (225 ng), andpolypeptides, NELF-A to -D. RD alone does not suffice
the different protein factors were preincubated for 45 min at 308Cfor NELF activity, suggesting that the other subunits
and processed as described (Wada et al., 1998a). In the P1.0 tran-are essential for its function. Molecular cloning of the
scription system, 2 ml of P1.0 concentration (Wada et al., 1998a)
remaining subunits will help understand the structure was used. In the reconstituted system, φFT (5 ml), rTFIIB (30 ng),
and function of NELF in more detail. rTFIIE (a, 5 ng; b, 3 ng), and rTFIIF (RAP74, 15 ng; RAP30, 15 ng)
RD was initially identified as a novel gene located in were used. Where indicated, 6 ml of P-TEFb fraction was included.
As for DSIF, either a P.1/P.3 concentration (2 ml) or rDSIF (p160 30the major histocompatibility complex class III region of
ng, p14 3 ng) was used. Primer extension analysis was performedhuman and mouse (Levi-Strauss et al., 1988). RD pos-
essentially as described (Ausubel et al., 1995). Primers used weresesses a putative RRM and a tract of alternating Arg-
B, 59-GAATAATGAGGAAAGGAGAGT-39; C, 59-GATGATAGATTTGG
Asp residues (RD motif). Since the two motifs are also GAAATATAA-39; D, 59-GGAGAGTAGGGTGGTATAG-39; E, 59-GGAG
found in the splicing factor U1 70K, RD has been postu- AGTAGGGTGGTATAG-39; and rev, 59-AGGAAACAGCTATGACC
ATG-39. The extension products were analyzed by 8% urea-PAGE.lated to be involved in mRNA splicing. However, we
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The expected lengths of the products were 29 nt (B), 43 nt (C), 69 Immunodepletion of NELF
Anti-RD antiserum or preimmune serum (10 ml each) was incubatednt (D), 98 nt (E), and 432 nt (rev).
with 20 ml protein G-Sepharose CL-6B (Amersham Pharmacia) for
1 hr at 48C, and the antibodies were immobilized on the beads. After
Oligo dC-Tailed Template Assays washing three times with NETN (50 mM Tris [pH 7.9], 150 mM NaCl,
The oligo dC-tailed template dC3.8 was prepared as described (Ki- 1 mM EDTA, 1% Nonidet P-40) and once with HGE.1, 200 ml of HeLa
tajima et al., 1994). To prepare the template carrying a 380 nt C-free nuclear extract was incubated with the beads for 2 hr at 48C. The
cassette, the plasmid p(C2AT)19 (Sawadogo and Roeder, 1985) was supernatants were collected and incubated with the new antibody-
digested with SmaI, and the G-free cassette was used in the reverse immobilized beads. Nuclear extracts passed twice or four times
orientation. For the elongation assays, 20 ml reactions containing the through the beads were prepared. Depletion of P-TEFb from the
template (100 ng), pol II (0.5±1.5 ml), and additional protein factors in nuclear extract was performed as described (Wada et al. 1998b).
0.53 HGE.05 plus 6 mM MgCl2 were preincubated for 20 min at Depletion of RD was monitored by immunoblotting with anti-RD
308C. Elongation was started by adding 3 ml of NTP mix (50 mM antiserum. The input and the depleted extracts (2 ml each) were
ATP/CTP/GTP, 10 mM UTP, and 1 mCi [a-32P] UTP). After 2 to 16 subjected to SDS-PAGE and transferred to a polyvinylidene difluo-
min, 5 ml aliquots were withdrawn, and the transcripts were analyzed ride membrane. The blot was sequentially incubated with anti-RD
on a 6% urea-polyacrylamide sequencing gel. In Figure 8B, elonga- antiserum (1:200 dilution) and anti-rat IgG secondary antibody con-
tion was started by adding the NTP mix lacking CTP. After 16 min, jugated with horseradish peroxidase (1:2,000 dilution; Dako) and
DSIF/NELF or buffer was added to the reactions and incubated for visualized with the ECL kit (Amersham Pharmacia).
an additional 10 min. Elongation was resumed by adding 10 mM
CTP, and the transcripts were analyzed as described above.
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